Dutasteride Reduces Prostatitis Symptoms Compared With Placebo in Men Enrolled in the REDUCE Study

Authors:

Abstract
Prostatitis was traditionally seen as a prostate centric condition, presumably related to inflammation or infection. However, our understanding of prostatitis, specifically the most prevalent category of chronic prostatitis/chronic pelvic pain syndrome, has evolved with the realization that the prostate is not the only relevant factor causing pain and voiding symptoms.1 x 1 Pontari, M.A. and Ruggieri, M.R. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004; 172: 839 Abstract | Full Text | Full Text PDF | PubMed | Scopus (164) | Google Scholar See all References The revelation that CP/CPPS may present with different clinical phenotypes2 x 2 Shoskes, D.A., Nickel, J.C., Dolinga, R. et al. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009; 73: 538 Abstract | Full Text | Full Text PDF | PubMed | Scopus (106) | Google Scholar See all References helps explain the diversity of the condition and the overall lack of efficacy of many treatments.3 x 3 Schaeffer, A.J. Clinical practice (Chronic prostatitis and the chronic pelvic pain syndrome ) . N Engl J Med. 2006; 355: 1690 Crossref | PubMed | Scopus (126) | Google Scholar See all References , 4 x 4 Nickel, J.C. Treatment of chronic prostatitis/chronic pelvic pain syndrome. in: P. Dahm, R.R. Dmochowski (Eds.) Evidence-Based Urology. 2nd ed. Wiley-Blackwell, Chichester, UK; 2010: 111–116 Crossref | Scopus (1) | Google Scholar See all References The recently introduced and validated UPOINT (Urinary, Psychosocial, Organ Specific, Infection, Neurologic/Systemic, Tenderness of Skeletal Muscles) phenotype categorization of CP/CPPS describes an organ specific phenotype, and shows that up to 60% of men with CP/CPPS have a least some prostate-organ specificity associated with the syndrome of genitourinary and pain symptoms.2 x 2 Shoskes, D.A., Nickel, J.C., Dolinga, R. et al. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009; 73: 538 Abstract | Full Text | Full Text PDF | PubMed | Scopus (106) | Google Scholar See all References This finding may explain why α-blockers are effective in some CP/CPPS studies5 x 5 Nickel, J.C. Role of alpha1-blockers in chronic prostatitis syndromes. BJU Int. 2008; 101: 11 Crossref | PubMed | Scopus (32) | Google Scholar See all References but not in others.6 x 6 Alexander, R.B., Propert, K.J., Schaeffer, A.J. et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med. 2004; 141: 581 Crossref | PubMed | Scopus (180) | Google Scholar See all References , 7 x 7 Nickel, J.C., Krieger, J.N., McNaughton-Collins, M. et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med. 2008; 359: 2663 Crossref | PubMed | Scopus (113) | Google Scholar See all References The growth and development of the prostate are at least partially under hormonal control. Thus, 5ARIs have shown benefit in treating or preventing BPH8 x 8 Roehrborn, C.G., Siami, P., Barkin, J. et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010; 57: 123 Abstract | Full Text | Full Text PDF | PubMed | Scopus (378) | Google Scholar See all References and prostate cancer.9 x 9 Andriole, G.L., Bostwick, D.G., Brawley, O.W. et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010; 362: 1192 Crossref | PubMed | Scopus (696) | Google Scholar See all References 5ARIs have been used for prostatitis treatment, with a number of publications attesting to their possible efficacy.10 x 10 Nickel, J.C. 5-α-Reductase therapy for chronic prostatitis. in: Textbook of Prostatitis. ISIS Medical Media, Oxford, UK; 1999: 333–338 Google Scholar See all References , 11 x 11 Holm, M. and Meyhoff, H.H. Chronic prostatic pain (A new treatment option with finasteride? ) . Scand J Urol Nephrol. 1997; 31: 213 Crossref | PubMed | Scopus (14) | Google Scholar See all References , 12 x 12 Leskinen, M., Lukkarinen, O., and Marttila, T. Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study. Urology. 1999; 53: 502 Abstract | Full Text | Full Text PDF | PubMed | Scopus (47) | Google Scholar See all References

This publication has 27 references indexed in Scilit: